Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children

Mostrar otras versiones (1)

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Descripción completa

Detalles Bibliográficos
Autores principales: Burns, Madeleine D, Boribong, Brittany P, Bartsch, Yannic C, Loiselle, Maggie, Davis, Jameson P, Lima, Rosiane, Edlow, Andrea G, Fasano, Alessio, Alter, Galit, Yonker, Lael M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863160/
https://www.ncbi.nlm.nih.gov/pubmed/35194616
http://dx.doi.org/10.1101/2022.01.05.22268617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863160/
https://www.ncbi.nlm.nih.gov/pubmed/35194616
http://dx.doi.org/10.1101/2022.01.05.22268617

Ejemplares similares